Previous 10 | Next 10 |
22nd Century Group ( XXII -1.7% ) announces the appointment of Michael Zercher as the company's chief operating officer. More news on: 22nd Century Group, Inc., Consumer stocks news, Read more ...
22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis research, announced today the appointment of Michael J. Zercher as the Company’s Chief Operating Offi...
With apologies to many other cannabis companies, this article focuses on the 21 of them for which we have been able to capture comprehensive investor-related data. In this article, we show how we capture the data and apply it to a proprietary algorithm to generate portfolio management decision...
22nd Century’s proposed VLN™ cigarettes continue to fall squarely within the nicotine range that public health officials anticipate will be mandated by the FDA. Company’s financial position remains strong; cash, cash equivalents, and short-term investment securitie...
FDA Inspection is an important milestone for 22nd Century’s VLN™ Cigarettes 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a world leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, a...
22nd Century exposes short seller as a promotor of incorrect and self-serving “fake news” 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a world leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/canna...
We discovered that the most important patents in XXII’s patent portfolio have now expired. In fact, some of them expired back in 2018! From the evidence we uncovered, we believe that these expired patents (the QPT family of patents) are the primary patents behind the Brand A/VLN (ve...
22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and hemp/cannabis research, announced today the hiring of John D. Pritchard as Vice President of Regulatory Science. Mr. Pritchard was...
HENDERSON NV / ACCESSWIRE / April 11, 2019 / With the market off to its best first quarter over the past 2 decades and the cannabis industry being one of the hottest in the market, now is an ideal time to research cannabis stocks. Today, we are highlighting a few cannabis stocks that aren't ...
Strategic collaboration will bolster 22nd Century’s position as a global leader in hemp/cannabis genetics. 22nd Century Group, Inc. (NYSE American: XXII ), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content tobacco, and h...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...